Bio-Techne Corp
NASDAQ:TECH
Bio-Techne Corp
NASDAQ:TECH
Price:
83.805 USD
1.16%
Market Closed
Updated:
May 19, 2024
P/B
Price to Book Value
Price to Book Value
6.6
Current
7.1
Median
2.5
Industry
Lower
than median
Higher
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=6.6
Market Cap
/
13.2B
Book Value of Equity
2B
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| US |
|
Bio-Techne Corp
NASDAQ:TECH
|
13.2B USD | 6.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
230.2B USD | 4.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
196.9B USD | 3.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45.2B USD | 7.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42B USD | 6.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.2B CHF | 4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56.1T KRW | 5.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.5B USD | -204.9 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26B USD | 2.8 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26B USD | 9.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
21.1B USD | 16.8 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
